Tibet Pharma Investors Escape Dismissal For Now In IPO Row
A New Jersey federal judge on Friday rejected a bid to remove three lead plaintiffs from a class action alleging Tibet Pharmaceuticals Inc. lied about its financial health before its 2011...To view the full article, register now.
Already a subscriber? Click here to view full article